390 related articles for article (PubMed ID: 34721547)
21. Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower-grade gliomas.
Ji Q; Huang K; Jiang Y; Lei K; Tu Z; Luo H; Zhu X
Cancer Med; 2022 May; 11(9):2020-2035. PubMed ID: 35142109
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of
Xu X; Zhong Z; Shao Y; Yi Y
Front Genet; 2021; 12():679097. PubMed ID: 34220951
[TBL] [Abstract][Full Text] [Related]
23. Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification.
Aili Y; Maimaitiming N; Maimaiti A; Liu W; Qin H; Ji W; Mahemuti Y; Wang Y; Wang Z
J Oncol; 2022; 2022():2621969. PubMed ID: 36504559
[TBL] [Abstract][Full Text] [Related]
24. TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle.
Jiang Y; Zhu C; Huang H; Huang G; Fu B; Xi X
BMC Cancer; 2023 Aug; 23(1):716. PubMed ID: 37528357
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of transferrin receptor protein 1 for predicting prognosis and immune infiltration in lower grade glioma.
Wu H; He H; Huang J; Wang C; Dong Y; Lin R; Cheng Z; Qiu Q; Hong L
Front Mol Neurosci; 2022; 15():972308. PubMed ID: 36483569
[TBL] [Abstract][Full Text] [Related]
26. Complement and coagulation cascades are associated with prognosis and the immune microenvironment of lower-grade glioma.
Yang J; Shen L; Yang J; Qu Y; Gong C; Zhou F; Liu Y; Luo M; Zhao L
Transl Cancer Res; 2024 Jan; 13(1):112-136. PubMed ID: 38410234
[TBL] [Abstract][Full Text] [Related]
27. Pan-Cancer Analysis of the Prognostic and Immunological Role of SMG5: A Biomarker for Cancers.
Yang L; Wei J; Ma X; Cheng R; Zhang H; Jin T
Oncology; 2024; 102(2):168-182. PubMed ID: 37699361
[TBL] [Abstract][Full Text] [Related]
28. ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma.
Zhang C; Wang L; Liu H; Deng G; Xu P; Tan Y; Xu Y; Liu B; Chen Q; Tian D
J Cancer; 2021; 12(10):2912-2920. PubMed ID: 33854592
[No Abstract] [Full Text] [Related]
29. Identification of COL1A1 associated with immune infiltration in brain lower grade glioma.
Ren J; Da J; Hu N
PLoS One; 2022; 17(7):e0269533. PubMed ID: 35789341
[TBL] [Abstract][Full Text] [Related]
30. The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma.
Zhu J; Lin Q; Zheng H; Rao Y; Ji T
Front Oncol; 2022; 12():897042. PubMed ID: 36505882
[TBL] [Abstract][Full Text] [Related]
31. IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
Peng S; Wang G; Cheng Z; Guo Z
Int J Gen Med; 2021; 14():4381-4393. PubMed ID: 34413671
[TBL] [Abstract][Full Text] [Related]
32. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
33. CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma.
Wang D; Sun H; Li X; Wang G; Yan G; Ren H; Hou B
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908101
[TBL] [Abstract][Full Text] [Related]
34. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
Deng X; Lin D; Zhang X; Shen X; Yang Z; Yang L; Lu X; Yu L; Zhang N; Lin J
J Cell Physiol; 2020 Oct; 235(10):7321-7331. PubMed ID: 32162312
[TBL] [Abstract][Full Text] [Related]
35. CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis.
Ye W; Luo C; Liu F; Liu Z; Chen F
Front Oncol; 2021; 11():634617. PubMed ID: 33680972
[TBL] [Abstract][Full Text] [Related]
36. Elevated RECQL1 expression predicts poor prognosis and associates with tumor immune infiltration in low-grade glioma.
Wang G; Cen Y; Wang C; Xiang W; Li S; Ming Y; Chen L; Zhou J
Transl Cancer Res; 2022 Jun; 11(6):1552-1564. PubMed ID: 35836526
[TBL] [Abstract][Full Text] [Related]
37. The N6-Methylandenosine-Related Gene
Jiang X; Shi Y; Chen X; Xu H; Huang X; Li L; Pu J
Front Mol Biosci; 2022; 9():773662. PubMed ID: 35309512
[TBL] [Abstract][Full Text] [Related]
38. Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas.
Wang M; Jia J; Cui Y; Peng Y; Jiang Y
Brain Sci; 2021 Nov; 11(11):. PubMed ID: 34827528
[No Abstract] [Full Text] [Related]
39. Comprehensive Prognostic Analysis of Immune Implication Value and Oxidative Stress Significance of NECAP2 in Low-Grade Glioma.
Lu Z; Chen Y; Chen S; Zhu X; Wang C; Wang Z; Yao Q
Oxid Med Cell Longev; 2022; 2022():1494520. PubMed ID: 36531205
[TBL] [Abstract][Full Text] [Related]
40. Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma.
Liu H; Tao T
Front Oncol; 2022; 12():1015850. PubMed ID: 36605437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]